Correspondence |

Efalizumab-Associated Guillain-Barré Syndrome

Frank Victor, MD; Kavita Menon, MD; Jo-Ann M. Latkowski, MD; Adolfo Fernandez-Obregon, MD; Bruce E. Strober, MD, PhD
Arch Dermatol. 2008;144(10):1396-1397. doi:10.1001/archderm.144.10.1396.
Text Size: A A A
Published online


We report a case of Guillain-Barré syndrome associated with efalizumab therapy for chronic plaque psoriasis.

Mohan  NEdward  ETCupps  TR  et al.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001;44 (12) 2862- 2869
Shin  ISBaer  ANKwon  HJ  et al.  Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006;54 (5) 1429- 1434
Magnano  MDRobinson  WHGenovese  MC Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 2004;22 (5) ((suppl 35)) S134- S140
 Raptiva (efalizumab) [package insert].  South San Francisco, CA Genentech Inc2005;
European Medicines Agency, Procedural steps taken and scientific information after the authorisation: Raptiva. http://www.emea.europa.eu/humandocs/Humans/EPAR/raptiva/raptiva.htm. Accessed September 20, 2007

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles